A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1

NCT06462404 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcolepsy Type 1 (NT1)

Interventions

DRUG: E2086
DRUG: E2086 Placebo
DRUG: Active Comparator
DRUG: Active Comparator Placebo

Sponsor

Eisai Inc.